Clinical Trial Update: AM-111 in the Treatment of Acute Inner Ear Hearing Loss [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for AM-111 in the treatment of acute inner ear hearing loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss

Drugs mentioned

• AM-111

Snippet

Sponsor: Auris Medical AG | Conditions: Hearing Loss | Phase 3 | Status: COMPLETED